[LXRX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
04-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -45.30%
YoY- -78.42%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 1,130 702 162 317 24 28 39 841.42%
PBT -48,397 -48,244 -50,525 -44,904 -31,934 -30,494 -23,387 62.31%
Tax 101 -2,977 2,854 1,152 -1,029 216 292 -50.69%
NP -48,397 -48,244 -50,525 -44,904 -30,905 -30,710 -23,679 60.98%
Tax Rate - - - - - - - -
Total Cost 49,527 48,946 50,687 45,221 30,929 30,738 23,718 63.29%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -4,282.92 -6,872.36 -31,188.27 -14,165.30 -128,770.83 -109,678.57 -60,715.38 -82.90%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.20 -0.20 -0.21 -0.22 -0.16 -0.16 -0.14 26.81%
EPS Diluted -0.20 -0.20 -0.21 -0.22 -0.16 -0.16 -0.14 26.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.